Hepatitis C virus infection among thai blood donors: Antibody prevalence, risk factors and development of risk screening form

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 1, 2004, Pages 147-154

  Luksamijarulkul, Pipat ^a   Thammata, Nantaporn ^b   Sujirarat, Dusit ^a   Tiloklurs, Mujarin ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Umphang Community Hospital   (Thailand)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY TITER; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG ABUSE; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; ROC CURVE; SEXUALLY TRANSMITTED DISEASE; THAILAND; VALIDATION PROCESS;

EID: 3042758536     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th National Seminar on Epidemiology, 1995: 146-7.
2. Cohen J. The scientific challenge of hepatitis C. Science 1999; 285: 26-30.
3. Daw MA, Elkaber MA, Drah AM, et al. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Sandi Med J 2002; 23: 1356-60.
4. Donahue JG, Nelson KE, Munoz A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991; 134: 1206-11.
5. Gilson RJ, De Ruiter A, Waite J, et al. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Dis 1998; 74: 110-5.
6. Holland CA, Ma Y, Moscicki B, Durako SJ, Levin L, Wilson CM. Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: findings of the REACH Study Adolescent Medicine HIV/AIDS Research Network. Sex Transm Dis 2000; 27: 296-303.
7. Louisirirotchanakul S, Thongput A, Wasi C, Thongcharoen P. Comparison of six anti-HCV second generation assays. Asian Pac J Allergy Immunol 1992; 10 (suppl): POM-105.
8. Luksamijarulkul P, Plucktaweesak S. High hepatitis C seroprevalence in Thai intravenous drug abusers and qualitative risk analysis. Southeast Asian J Trop Med Public Health 1996; 27: 654-8.
9. Luksamijarulkul P, Daengbubpha A. Hepatitis C antibody prevalence and risk factors of some female sex workers in Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 507-12.
10. 24 antigen and risk behaviors among some groups of female sex workers. Chula Med J 1998; 42: 599-607.
11. Luksamijarulkul P, Khemnak P, Pacheun O. Human immunodeficiency virus and hepatitis C virus infections among patients attending sexually transmitted disease clinics, Regional 2, Thailand. Asia Pac J Public Health 2000; 12: 41-5.
12. Luksamijarulkul P, Khemnak P, Luksamijarulkul S. A case-control study of hepatitis C virus infection among sexually transmitted disease patients. Chula Med J 2001; 45: 413-21.
13. Nur YA, Groen J, Elmi AM, Ott A, Osterhaus AD. Prevalence of serum antibodies against blood-borne and sexually transmitted agents in selected groups in Somalia. Epidemiol Infect 2000; 124: 137-41.
14. Romanowski B, Preiksaitis J, Campbell P, et al. Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics. Sex Transm Dis 2003; 30: 33-8.
15. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91: 31-7.
16. Songsivilai S, Jinathongthai S, Wongsena W, Tiangpitayakorn C, Kharakul T. High prevalence of hepatitis C infection among blood donors in Northeastern Thailand. Am J Trop Med Hyg 1997; 57: 66-9.
17. Stary A, Kopp W, Hofmann H, Heller-Vitouch C, Kunz C. Sero-epidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis 1992; 19: 252-8.
18. Tanikawa K. Relationship between hepatitis C and alcoholic liver disease. Asian Med J 1994; 37: 165-70.
19. Zoulim F, Chevallier M, Maynard M, Trepo C. Clinical consequences of hepatitis C virus infection. Rev Med Virol 2003; 13: 57-68.